vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Real Brokerage Inc is the larger business by last-quarter revenue ($568.5M vs $308.4M, roughly 1.8× Astera Labs, Inc.). Astera Labs, Inc. runs the higher net margin — 26.0% vs -0.1%, a 26.1% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (93.4% vs 52.6%).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

ALAB vs REAX — Head-to-Head

Bigger by revenue
REAX
REAX
1.8× larger
REAX
$568.5M
$308.4M
ALAB
Growing faster (revenue YoY)
ALAB
ALAB
+40.8% gap
ALAB
93.4%
52.6%
REAX
Higher net margin
ALAB
ALAB
26.1% more per $
ALAB
26.0%
-0.1%
REAX

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ALAB
ALAB
REAX
REAX
Revenue
$308.4M
$568.5M
Net Profit
$80.3M
$-447.0K
Gross Margin
76.3%
7.9%
Operating Margin
20.1%
-0.1%
Net Margin
26.0%
-0.1%
Revenue YoY
93.4%
52.6%
Net Profit YoY
152.4%
82.7%
EPS (diluted)
$0.44
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
REAX
REAX
Q1 26
$308.4M
Q4 25
$270.6M
Q3 25
$230.6M
$568.5M
Q2 25
$191.9M
$540.7M
Q1 25
$159.4M
$354.0M
Q4 24
$141.1M
Q3 24
$113.1M
$372.5M
Q2 24
$76.8M
Net Profit
ALAB
ALAB
REAX
REAX
Q1 26
$80.3M
Q4 25
$45.0M
Q3 25
$91.1M
$-447.0K
Q2 25
$51.2M
$1.5M
Q1 25
$31.8M
$-5.0M
Q4 24
$24.7M
Q3 24
$-7.6M
$-2.6M
Q2 24
$-7.5M
Gross Margin
ALAB
ALAB
REAX
REAX
Q1 26
76.3%
Q4 25
75.6%
Q3 25
76.2%
7.9%
Q2 25
75.8%
8.9%
Q1 25
74.9%
9.6%
Q4 24
74.0%
Q3 24
77.7%
8.6%
Q2 24
77.9%
Operating Margin
ALAB
ALAB
REAX
REAX
Q1 26
20.1%
Q4 25
24.7%
Q3 25
24.0%
-0.1%
Q2 25
20.7%
0.3%
Q1 25
7.1%
-1.5%
Q4 24
0.1%
Q3 24
-7.9%
-0.7%
Q2 24
-31.7%
Net Margin
ALAB
ALAB
REAX
REAX
Q1 26
26.0%
Q4 25
16.6%
Q3 25
39.5%
-0.1%
Q2 25
26.7%
0.3%
Q1 25
20.0%
-1.4%
Q4 24
17.5%
Q3 24
-6.7%
-0.7%
Q2 24
-9.8%
EPS (diluted)
ALAB
ALAB
REAX
REAX
Q1 26
$0.44
Q4 25
$0.25
Q3 25
$0.50
$0.00
Q2 25
$0.29
$0.01
Q1 25
$0.18
$-0.02
Q4 24
$1.23
Q3 24
$-0.05
$-0.01
Q2 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$148.3M
$38.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.5B
$53.6M
Total Assets
$1.7B
$145.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
REAX
REAX
Q1 26
$148.3M
Q4 25
$167.6M
Q3 25
$140.4M
$38.7M
Q2 25
$162.3M
$49.7M
Q1 25
$86.4M
$24.7M
Q4 24
$79.6M
Q3 24
$126.1M
$22.6M
Q2 24
$421.1M
Stockholders' Equity
ALAB
ALAB
REAX
REAX
Q1 26
$1.5B
Q4 25
$1.4B
Q3 25
$1.3B
$53.6M
Q2 25
$1.1B
$49.2M
Q1 25
$1.0B
$32.8M
Q4 24
$964.8M
Q3 24
$889.6M
$29.8M
Q2 24
$845.3M
Total Assets
ALAB
ALAB
REAX
REAX
Q1 26
$1.7B
Q4 25
$1.5B
Q3 25
$1.4B
$145.2M
Q2 25
$1.3B
$149.4M
Q1 25
$1.1B
$100.5M
Q4 24
$1.1B
Q3 24
$983.1M
$102.5M
Q2 24
$915.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
REAX
REAX
Operating Cash FlowLast quarter
$74.6M
$8.8M
Free Cash FlowOCF − Capex
$8.4M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
0.93×
TTM Free Cash FlowTrailing 4 quarters
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
REAX
REAX
Q1 26
$74.6M
Q4 25
$95.3M
Q3 25
$78.2M
$8.8M
Q2 25
$135.4M
$41.0M
Q1 25
$10.5M
$15.9M
Q4 24
$39.7M
Q3 24
$63.5M
$7.2M
Q2 24
$29.8M
Free Cash Flow
ALAB
ALAB
REAX
REAX
Q1 26
Q4 25
$76.6M
Q3 25
$65.9M
$8.4M
Q2 25
$133.3M
$40.8M
Q1 25
$6.0M
$15.7M
Q4 24
$24.3M
Q3 24
$46.8M
$6.8M
Q2 24
$28.5M
FCF Margin
ALAB
ALAB
REAX
REAX
Q1 26
Q4 25
28.3%
Q3 25
28.6%
1.5%
Q2 25
69.5%
7.5%
Q1 25
3.7%
4.4%
Q4 24
17.2%
Q3 24
41.4%
1.8%
Q2 24
37.1%
Capex Intensity
ALAB
ALAB
REAX
REAX
Q1 26
Q4 25
6.9%
Q3 25
5.3%
0.1%
Q2 25
1.1%
0.0%
Q1 25
2.8%
0.1%
Q4 24
10.9%
Q3 24
14.8%
0.1%
Q2 24
1.7%
Cash Conversion
ALAB
ALAB
REAX
REAX
Q1 26
0.93×
Q4 25
2.12×
Q3 25
0.86×
Q2 25
2.64×
27.13×
Q1 25
0.33×
Q4 24
1.61×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons